When patients are diagnosed with pattern dystrophy, one of their first questions is often about treatment options. Currently, there is no medical or surgical cure for pattern dystrophy, nor are there treatments that can reverse the pigment deposits in the macula or halt the underlying genetic progression of the disease. However, this does not mean there is nothing to be done. The management of pattern dystrophy focuses on monitoring the condition, treating specific complications if they arise, and maximizing remaining vision.
The cornerstone of managing pattern dystrophy is regular, comprehensive eye examinations. Because the disease progresses slowly, your retinal specialist will want to monitor your macula periodically using imaging techniques like optical coherence tomography (OCT) and fundus autofluorescence (FAF). This monitoring is crucial for detecting the most significant threat to vision in pattern dystrophy: choroidal neovascularization (CNV).
CNV occurs when abnormal, fragile blood vessels grow beneath the retina and leak fluid or blood into the macula. This can cause sudden and severe central vision loss. Fortunately, if CNV develops, highly effective treatments are available. The standard of care involves intravitreal injections of anti-VEGF (vascular endothelial growth factor) medications. These drugs, which include medications like ranibizumab, aflibercept, and bevacizumab, block the signal that causes these abnormal blood vessels to grow and leak. With prompt and consistent treatment, anti-VEGF injections can stabilize vision and, in many cases, improve it.
In addition to medical interventions for complications, lifestyle choices may play a role in supporting overall macular health. While not a cure, protecting your eyes from excessive ultraviolet (UV) light by wearing sunglasses, maintaining a balanced diet rich in leafy greens and omega-3 fatty acids, and avoiding smoking are generally recommended for anyone with a macular condition. Smoking, in particular, is a known risk factor for accelerating macular degeneration and should be strictly avoided.
Looking to the future, the pipeline for inherited retinal disease treatments is robust. Researchers are actively exploring gene therapies, CRISPR gene editing, and neuroprotective drugs aimed at preserving photoreceptor cells. While these therapies are still in the preclinical or early clinical trial phases for pattern dystrophy, the rapid pace of scientific advancement offers significant hope.
In the meantime, maximizing your current vision through low vision rehabilitation is a vital part of treatment. Low vision specialists can introduce you to devices and strategies that make daily tasks easier. Patients should always consult their healthcare provider to discuss their specific diagnosis, monitor for complications, and stay informed about emerging therapies.